Recent investigations have revealed an upregulation of CARD16 in malignant gliomas, particularly in GBM, where it impedes apoptosis through the ignition of the NF‐κB signaling cascade, thereby fostering the proliferation of tumor cells. Here, NFKB1 is linked to glioblastoma.